StockData
BIO-TECHNE Corp logo

BIO-TECHNE Corp (TECH) balance sheet

TECHNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q/A on Nov 12, 2026Score 12/3038% above fair value
$72.75+0.12 (+0.17%)

Close on Nov 18, 2026Market cap $11.43BP/E 62.7Yield 0.44%

BIO-TECHNE Corp balance sheet

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
65.8%
Operating margin
20.7%
Net margin
–
Return on equity, FY2026
–

Financial strength

Current ratio
4.55
Debt to equity
0.09
Debt to assets
7.7%
Cash to current liabilities
161.7%

Valuation

P/E ratio
62.7
Price to sales
9.40
Price to book
5.42
Dividend yield
0.44%

See a number that looks wrong?